Skip to main content

Sun-A Lim

Ewha Womans University · Medicine

About the Lab

Professor Sun-A Lim's research lab focuses on the intersection of immunometabolism and cardiovascular disease, with a particular emphasis on understanding how metabolic reprogramming influences regulatory T cells in cancer immunity and the differential cardiovascular outcomes associated with thiazide diuretics. The lab investigates the metabolic adaptations of Tregs within the tumor microenvironment to uncover novel therapeutic targets for cancer immunotherapy, while also exploring the clinical implications of antihypertensive drug selection on long-term cardiovascular health. Current research directions include metabolic regulation of immune cell function and pharmacological outcomes in chronic disease.

immunometabolismregulatory T cellscancer immunotherapythiazide diureticscardiovascular outcomes

Research Overview

Papers
2
Total Citations
1
Papers (5y)
2
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
2total
2025
Citations per year (5y)
1total
2025

Selected Papers

2
1
Article|1 citations·2025
Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?
Jihyoun Kim, Jiaoran Li, Jun Wei, 임선아

Regulatory T (Treg) cells are essential for maintaining immune homeostasis by suppressing excessive immune responses. In the context of cancer, however, Tregs promote immune evasion and tumor progression, particularly through their unique adaptations within the tumor microenvironment (TME). Recent research has emphasized how metabolic characteristics shape Treg activation, migration, and immunosuppressive function, revealing the impact of metabolic pathways on Treg fitness in homeostasis and wit

2
Article|0 citations·2025
Comparison of cardiovascular outcomes between chlorthalidone and hydrochlorothiazide in hypertensive patients
S Lim, J H Kim, S M Oh, S J Hong, C W Yu, H J Joo, Y H Kim, E J Kim
SJR Q1European Heart Journal

Abstract Background Chlorthalidone and hydrochlorothiazide are widely used thiazide diuretics for hypertension management. This study aimed to evaluate and compare the cardiovascular outcomes of patients treated with chlorthalidone versus hydrochlorothiazide. Methods This multicenter retrospective cohort study utilized data from our medical center, derived from electronic health records. A total of 14,257 hypertensive patients treated with either chlorthalidone (n = 1,920) or hydrochlorothiazide

Cardiology and Cardiovascular MedicineMedicine

Research Areas

Cardiology and Cardiovascular Medicine

Dive deeper into Sun-A Lim's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.